WebDec 19, 2024 · CAMBRIDGE, Mass. and NEW YORK, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of ... WebApr 25, 2024 · CAMBRIDGE, Mass. and NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of MasterKey therapies, today announced that it is realigning its resources to focus on key near-term value drivers and …
Black Diamond Therapeutics Announces Changes to Board of …
WebFeb 22, 2024 · CAMBRIDGE, Mass. and NEW YORK, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of ... WebApr 10, 2024 · CAMBRIDGE, Mass. and NEW YORK, April 10, 2024 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of ... costa verde hotel costa rica
Black Diamond Therapeutics LinkedIn
WebDec 31, 2024 · CAMBRIDGE, Mass. and NEW YORK, March 09, 2024 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage precision oncology medicine company developing MasterKey therapies designed to overcome limitations of existing therapies by targeting families of oncogenic driver … WebApr 10, 2024 · CAMBRIDGE, Mass. and NEW YORK, April 10, 2024 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine … WebMay 7, 2024 · Patient enrollment and dosing in the Phase 1/2 clinical trial of BDTX-189 continue to track in line with projections at initiation of the study, w... costa verde immobilier moriani